Year: 2024

HIGHfield_logo_horizontal_FINAL_English_28329dedr

HighField Biopharmaceuticals’ mRNA-based HFG1 Demonstrates Potential as a Longer Acting GLP-1R Agonist for Diabetic Control and Weight Loss

Preclinical results in naturally occurred diabetic monkeys were presented at the American Diabetes Association 84th Scientific Sessions, June 21-24, 2024...

news_6

Luxshare Precision’s Global Footprint and Scalable Manufacturing Capabilities Strengthen its Position as a Trusted Supplier Amidst Robust Human Rights Protections

HONG KONG SAR - Media OutReach Newswire - 24 June 2024 - Luxshare Precision, a prominent global technology manufacturer, has...

Takeda_Red_Logo_2021-4

Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One...